Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co LtdfiledCriticalShiseido Co Ltd
Priority to JP2005502978ApriorityCriticalpatent/JPWO2004075621A1/ja
Priority to US10/588,780prioritypatent/US20070134265A1/en
Priority to EP04733645Aprioritypatent/EP1514537A4/en
Publication of WO2004075621A2publicationCriticalpatent/WO2004075621A2/ja
Publication of WO2004075621A1publicationCriticalpatent/WO2004075621A1/ja
Publication of WO2004075621A3publicationCriticalpatent/WO2004075621A3/ja
Anticipated expirationlegal-statusCritical
Priority to US12/320,088prioritypatent/US20090136540A1/en
Fusion peptide grafted with tat peptide to human type-i collagen derived peptide, its preparation method, and cosmetic composition for anti-aging comprising the same
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue